- Presentations
- 4
- Markets
- 1
Vabrinty is a brand of Leuprolide marketed by Uronova Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Leuprolide
- Brand owner
- Uronova Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 22.5 mg/0.375 mL extended-release injectable suspension, 30 mg/0.5 mL extended-release injectable suspension, 45 mg/0.375 mL extended-release injectable suspension, 7.5 mg/0.25 mL extended-release injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Vabrinty 22.5 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chain | Uronova Pharmaceuticals | US FDA | Available on request |
| Vabrinty 30 mg/0.5 mL extended-release injectable suspensionSubcutaneous Cold chain | Uronova Pharmaceuticals | US FDA | Available on request |
| Vabrinty 45 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chain | Uronova Pharmaceuticals | US FDA | Available on request |
| Vabrinty 7.5 mg/0.25 mL extended-release injectable suspensionSubcutaneous Cold chain | Uronova Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Leuprolide.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Vabrinty
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.